158 related articles for article (PubMed ID: 27586552)
1. Angiotensin-converting enzyme inhibitors reduce oxidative stress intensity in hyperglicemic conditions in rats independently from bradykinin receptor inhibitors.
Mikrut K; Kupsz J; Kozlik J; Krauss H; Pruszynska-Oszmałek E; Gibas-Dorna M
Croat Med J; 2016 Aug; 57(4):371-80. PubMed ID: 27586552
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
[TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin convertase inhibitors and AT1 angiotensin receptor antagonists on the development of oxidative stress in the kidney of diabetic rats.
Kedziora-Kornatowska K
Clin Chim Acta; 1999 Sep; 287(1-2):19-27. PubMed ID: 10509893
[TBL] [Abstract][Full Text] [Related]
4. Superoxide dismutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liver.
de Cavanagh EM; Inserra F; Ferder L; Romano L; Ercole L; Fraga CG
FEBS Lett; 1995 Mar; 361(1):22-4. PubMed ID: 7890034
[TBL] [Abstract][Full Text] [Related]
5. Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats.
Abd El-Aziz MA; Othman AI; Amer M; El-Missiry MA
J Appl Toxicol; 2001; 21(6):469-73. PubMed ID: 11746193
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus.
Bild W; Hritcu L; Stefanescu C; Ciobica A
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():79-88. PubMed ID: 23266710
[TBL] [Abstract][Full Text] [Related]
7. The effect of bradykinin on the oxidative state of rats with acute hyperglycaemia.
Mikrut K; Paluszak J; Kozlik J; Sosnowski P; Krauss H; Grześkowiak E
Diabetes Res Clin Pract; 2001 Feb; 51(2):79-85. PubMed ID: 11165687
[TBL] [Abstract][Full Text] [Related]
8. Enalapril attenuates oxidative stress in diabetic rats.
de Cavanagh EM; Inserra F; Toblli J; Stella I; Fraga CG; Ferder L
Hypertension; 2001 Nov; 38(5):1130-6. PubMed ID: 11711510
[TBL] [Abstract][Full Text] [Related]
9. Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.
Liu YH; Liu LY; Wu JX; Chen SX; Sun YX
J Cardiovasc Pharmacol; 2006 Jan; 47(1):82-8. PubMed ID: 16424790
[TBL] [Abstract][Full Text] [Related]
10. Long-term angiotensin II inhibition increases mitochondrial nitric oxide synthase and not antioxidant enzyme activities in rat heart.
Costa LE; La-Padula P; Lores-Arnaiz S; D'Amico G; Boveris A; Kurnjek ML; Basso N
J Hypertens; 2002 Dec; 20(12):2487-94. PubMed ID: 12473874
[TBL] [Abstract][Full Text] [Related]
11. Does captopril change oxidative stress in puromycin aminonucleoside nephropathy?
Djordjevic VB; Cosic V; Pavlovic D; Vlahovic P; Jevtovic T; Kocic G; Savic V
Ren Fail; 2000; 22(5):535-44. PubMed ID: 11041286
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure responses to acute or chronic captopril in mice with disruption of bradykinin B2-receptor gene.
Emanueli C; Angioni GR; Anania V; Spissu A; Madeddu P
J Hypertens; 1997 Dec; 15(12 Pt 2):1701-6. PubMed ID: 9488225
[TBL] [Abstract][Full Text] [Related]
13. Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts.
Anderson B; Khaper N; Dhalla AK; Singal PK
Can J Cardiol; 1996 Oct; 12(10):1099-104. PubMed ID: 9191504
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin (B2) independent effect of captopril on the development of pressure overload cardiac hypertrophy.
Turcani M; Rupp H
Mol Cell Biochem; 2000 Sep; 212(1-2):219-25. PubMed ID: 11108154
[TBL] [Abstract][Full Text] [Related]
15. Lutein attenuates oxidative stress markers and ameliorates glucose homeostasis through polyol pathway in heart and kidney of STZ-induced hyperglycemic rat model.
Sharavana G; Joseph GS; Baskaran V
Eur J Nutr; 2017 Dec; 56(8):2475-2485. PubMed ID: 27488609
[TBL] [Abstract][Full Text] [Related]
16. Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues.
de Cavanagh EM; Inserra F; Ferder L; Fraga CG
Am J Physiol Regul Integr Comp Physiol; 2000 Mar; 278(3):R572-7. PubMed ID: 10712274
[TBL] [Abstract][Full Text] [Related]
17. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
Elmarakby AA; Williams JM; Imig JD; Pollock JS; Pollock DM
Vascul Pharmacol; 2007 Feb; 46(2):144-51. PubMed ID: 17112788
[TBL] [Abstract][Full Text] [Related]
18. Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.
Chauvin B; Richer C; Giudicelli JF
Br J Pharmacol; 1995 Oct; 116(4):2229-36. PubMed ID: 8564253
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.
Ibrahim MA; Ashour OM; Ibrahim YF; El-Bitar HI; Gomaa W; Abdel-Rahim SR
Pharmacol Res; 2009 Nov; 60(5):373-81. PubMed ID: 19467331
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiotesin-converting enzyme by quercetin alters the vascular response to brandykinin and angiotensin I.
Häckl LP; Cuttle G; Dovichi SS; Lima-Landman MT; Nicolau M
Pharmacology; 2002 Aug; 65(4):182-6. PubMed ID: 12174832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
